The Neuroblastoma Advanced Therapies Center at Cincinnati Children’s is a leading center for the development and clinical testing of new approaches to neuroblastoma. Our physicians and researchers work closely together to quickly move research breakthroughs from the lab to the patient. Current clinical research initiatives in neuroblastoma focus on the development of new treatments using:
- Novel targeted therapies
- New approaches to high-dose chemotherapy
- Targeted radiopharmaceutical therapies
Cincinnati Children’s researchers are investigating novel agents or combinations of agents to treat the most difficult forms of relapsed or refractory neuroblastoma. A number of Cincinnati Children’s pilot projects have subsequently been developed into national trials by the Children’s Oncology Group and other national clinical research consortia.
> Learn more about our world-class research on cancer in the Division of Oncology.
National Referral Center
Cincinnati Children’s is a major referral center for the National Cancer Institute's two new pediatric research initiatives for children with high-risk neuroblastoma: the Pediatric Phase I Consortium and the New Approaches to Neuroblastoma Therapy Consortium. Many of our physicians serve in leadership positions for these and other pediatric cancer organizations, further strengthening our link to the latest clinical research opportunities.